1. Home
  2. PLG vs DERM Comparison

PLG vs DERM Comparison

Compare PLG & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Platinum Group Metals Ltd. (Canada)

PLG

Platinum Group Metals Ltd. (Canada)

HOLD

Current Price

$1.28

Market Cap

167.4M

Sector

N/A

ML Signal

HOLD

Logo Journey Medical Corporation

DERM

Journey Medical Corporation

HOLD

Current Price

$6.10

Market Cap

190.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PLG
DERM
Founded
2000
2014
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
167.4M
190.3M
IPO Year
2002
2021

Fundamental Metrics

Financial Performance
Metric
PLG
DERM
Price
$1.28
$6.10
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$12.67
AVG Volume (30 Days)
888.1K
258.2K
Earning Date
04-10-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
34.72
EPS
N/A
N/A
Revenue
N/A
$61,858,000.00
Revenue This Year
N/A
$39.72
Revenue Next Year
N/A
$63.24
P/E Ratio
N/A
N/A
Revenue Growth
N/A
10.20
52 Week Low
$1.18
$4.31
52 Week High
$4.04
$9.56

Technical Indicators

Market Signals
Indicator
PLG
DERM
Relative Strength Index (RSI) 41.11 39.12
Support Level $1.25 $5.80
Resistance Level $1.48 $6.59
Average True Range (ATR) 0.07 0.39
MACD 0.01 -0.11
Stochastic Oscillator 39.13 8.97

Price Performance

Historical Comparison
PLG
DERM

About PLG Platinum Group Metals Ltd. (Canada)

Platinum Group Metals Ltd is a development-stage company, conducts work on mineral properties it has staked or acquired by way of option agreements in the Republic of South Africa. Key metals of economic interest on the company's mineral properties include platinum, palladium, rhodium, gold, copper, and nickel. The company operates in one segment, the development of the Waterberg Project in South Africa, and geographically in Canada and South Africa.

About DERM Journey Medical Corporation

Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its current product portfolio includes FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. The company views its operations and manages its business in one segment, which reflects products for the treatment of dermatological conditions. The dermatological segment derives revenues from the sale of branded and authorized general prescription products that treat certain dermatological conditions.

Share on Social Networks: